|drug1825||Lifestyle change promotion program Wiki||1.00|
|drug3674||Written Information Wiki||1.00|
|drug2042||Mindfullness based cognitive program Wiki||1.00|
|D061218||Depressive Disorder, Treatment-Resistant NIH||1.00|
|D003866||Depressive Disorder NIH||0.20|
There is one clinical trial.
The aim of the study is to identify the knowledge that CCSPT nurses have in relation to care aimed at addressing anxiety, fear or loneliness and the use they have made of it in the recent crisis. The design of the research/action will also enable the training of the participating professionals to improve nursing care in these areas in the future
Description: % of care actions identified by nursesMeasure: Rate of care actions identified by nurses Time: 6 months after care
Description: % of care actions taken by nursesMeasure: Rate of care actions taken by nurses Time: 6 months after care
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports